| Affiliation: | 1. Department of ENT and Maxillofacial Surgery, Maison de Santé Protestante de Bordeaux-Bagatelle, Talence, France;2. Medical practice, Les Pavillons-sous-bois, France;3. Department of Sleep Medicine, Hôpital Hôtel-Dieu, Assistance publique – Hôpitaux de Paris, Paris, France;4. Medical practice, Levallois Perret, France;5. Medical practice, La Rochelle, France;6. Charcot Clinic, Sainte-Foy-les-Lyon, France;7. Department of ENT, Head and Neck Surgery, E. Herriot University Hospital, Lyon, France;8. Beau Soleil Clinic, Montpellier, France;9. Paediatric ENT Department, Necker – Enfants Malades University Hospital, Assistance publique–Hôpitaux de Paris, Paris, France;10. Department of ENT, Head and Neck Surgery, Créteil Intercommunal Hospital and Henri Mondor University Hospital, Assistance publique – Hôpitaux de Paris, Créteil, France |
| Abstract: | The treatment of sleep disorders has been strongly impacted by the COVID-19 pandemic. When the lockdown is over, resumption of usual patient care will require precautions to limit the risk of contamination for patients and caregivers. In this document, the French Association of Otorhinolaryngology and Sleep disorders (AFSORL) and the French Society of Otorhinolaryngology (SFORL) put forward a summary of the measures for continuing the treatment of sleep apnoea syndrome in these new practice conditions. Emphasis is placed on teleconsultation, methods of nocturnal sleep studies, the conditions for treatment by continuous positive airway pressure (CPAP) ventilation, and the postponement of more invasive treatments. |
